Author(s):
Wajid Ahmad, Riyaz Khan, Razia Pathan, Vishal Jain, Dipali Rajput
Email(s):
wajidahmad806@gmail.com
DOI:
10.52711/2321-5836.2026.00007 
Address:
Wajid Ahmad*, Riyaz Khan, Razia Pathan, Vishal Jain, Dipali Rajput
Department of Pharmacology, Campus Institute of Pharmacy, Chicholi, Betul - 460001.
*Corresponding Author
Published In:
Volume - 18,
Issue - 1,
Year - 2026
ABSTRACT:
Because it entails the use of de-risked compounds and may result in reduced total development costs and shorter development timeframes, repurposing "old" medications to treat common and uncommon diseases is increasingly becoming an appealing prospect given the high attrition rates, significant costs, and sluggish pace of new drug discovery and development. Finding repurposable medication candidates has been approached in a number of data-driven and experimental ways, but there are significant technological and regulatory obstacles that must be overcome. In order to rationally discover or identify new uses for pharmacological molecules, drug repositioning combines the efforts of activity-based or experimental and in silico-based or computational methodologies. Therefore, it is thought to be a new approach in which medications that have previously been shown safe for use in humans are redirected based on a legitimate target molecule to cure diseases, especially those that are uncommon, challenging to treat, or ignored. In this review, we outline strategies for medication repurposing, sometimes referred to as drug repositioning, talk about the difficulties the purposing community faces, and suggest creative solutions to these difficulties in order to help achieve the full potential of drug repurposing.
Cite this article:
Wajid Ahmad, Riyaz Khan, Razia Pathan, Vishal Jain, Dipali Rajput. Accelerating Drug Development: The Promise of Repurposing. Research Journal of Pharmacology and Pharmacodynamics. 2026;18(1):59-4. doi: 10.52711/2321-5836.2026.00007
Cite(Electronic):
Wajid Ahmad, Riyaz Khan, Razia Pathan, Vishal Jain, Dipali Rajput. Accelerating Drug Development: The Promise of Repurposing. Research Journal of Pharmacology and Pharmacodynamics. 2026;18(1):59-4. doi: 10.52711/2321-5836.2026.00007 Available on: https://rjppd.org/AbstractView.aspx?PID=2026-18-1-7
REFERENCES:
1. Trejo-Castro AI, Martinez-Ledesma E, Martinez-Torteya A. A bibliometric review on in silico drug repurposing: Performance analysis, science mapping and text mining (2000–2023). Heliyon. 2025 May 1; 11(10).
2. Polamreddy P, Gattu N. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions. Drug Discovery Today. 2019 Mar 1; 24(3):789-95.
3. Hu S, Batool Z, Zheng X, Yang Y, Ullah A, Shen B. Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities. Journal of Pharmaceutical Analysis. 2025 Jan 1; 15(1):101084.
4. Raji RO, Balogun SM, Aliu TB, Badmus KO. Repositioning old drugs for new battles: The expanding role of drug repurposing in cancer, inflammation, and metabolic disease. BIOMED Natural and Applied Science. 2025; 5(2): 1-19.
5. Venkatachalam S, Jaiswal A, De A, Vijayakumar RK. Repurposing drugs for management of Alzheimer disease. Research Journal of Pharmacy and Technology. 2019 Jun 1; 12(6): 3078-88.
6. Adivarekar SS, Udugade BV, Biraje TM, Palamkar PS, Udugade SB, Gaikwad TK, Pujari MM, Kandele SV. Repurposing Orlistatanaloges: A Ligand-Based Screening Approach using Morgan Fingerprints for Novel Therapeutic agents for Obesity. Research Journal of Pharmacy and Technology. 2025 Jul 1; 18(7): 3051-6.
7. Malviya V, Khan A, Thakare V, Dangre K. Practical Handbook of Industrial Pharmacy-I (B. Pharm 3rd Year-SEM-V) Strictly As per the Syllabus of PCI. Chyren Publication;
8. Patel R, James V, Prajapati B. An update on selective estrogen receptor modulator: repurposing and formulations. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025 Jan 16:1-23.
9. Nimbalkar VV, Bhongal SA, Dhage NR, Barkade GD. Repurposing of Mebendazole as an Anticancer Agent: A Review. Research Journal of Pharmacy and Technology. 2025 Apr 1; 18(4): 1619-24.
10. Alaraj M. Pharmacological repurposed agents for COVID-19. Research Journal of Pharmacy and Technology. 2022;15(1): 441-6.
11. Malviya V, Ajmire P, Manekar S, Ingle G, Burakle P. Understanding fentanyl a synthetic piperidine opioid drug: Deciphering the pain-relieving double-edged sword. Asian Journal of Pharmacy and Technology. 2024; 14(2):97-102.
12. Irham LM, Nuryana Z, Perwitasari DA, Nuari YR, Sarasmita MA, Adikusuma W, Dania H, Maliza R, Cheung R. Worldwide publication trends of drug repurposing and drug repositioning in the science of medicine (2003-2022). Research Journal of Pharmacy and Technology. 2023; 16(3): 1333-41.
13. Malviya V, Tawar M, Burange P, Jodh R. A Brief Review on Resveratrol. Asian Journal of Research in Pharmaceutical Science. 2022 Jun 1; 12(2).
14. Alisha K, Tripti S. Repurposing statins as a potential ligand for estrogen receptor alpha via molecular docking. Research Journal of Pharmacy and Technology. 2021; 14(7):3757-62.
15. Aher PR, Aher RV, Ahire TS, Patil MB, Shahare HV, Gedam SS. Repurposing of Drugs: Updates and New Perspectives. Research Journal of Pharmacy and Technology. 2022 Sep 1; 15(9):4309-14.
16. Kharabe PM, Jumade PP, Khatale PN, Katolkar PP, Butle SR, Kshirsagar MD, Pendharkar VV, Sawale AV, Choudhari KS. Reverse phase, ion exchange, HILIC and mix-mode chromatography for the determination of metformin and evogliptin in human plasma and pharmaceutical formulations. Talanta Open. 2024 Aug 1; 9:100274.
17. Jajoo VS, Sawale AV. Recent advances in supercritical fluid chromatography. Research Journal of Science and Technology. 2024; 16(1):87-96.
18. Honale VS, Muneshwar SD, Sawale AV. Formulation and Evaluation of Oral Soft Jelly Containing Salbutamol Sulphate for the Treatment of Asthma. Journal of Drug Delivery & Therapeutics. 2023 Jun 1; 13(6): 118-24.
19. Jajoo VS, Shrirame DS, Sawale AV, Atram SC. Formulation and evaluation of Transdermal Patch for the treatment of Migraine. Journal of Drug Delivery & Therapeutics. 2023 May 1; 13(5): 47-52.
20. Fadnis JA, Sawale AV, Padmawar SS. Thalidomide: the journey from curse to boon. World J Bio Pharm Health Sci. 2023; 14(3): 149-59.
21. Malviya V, Pande S. Design and characterization of pH dependent phase transition system of almotriptan malate for nasal drug delivery system by employing factorial design. Ind. J. Pharm. Edu. Res. 2024 Jan 1; 58(1): 76-90.
22. Tighare KV, Sawale AV. Method development, validation and stress degradation study of teneligliptin by RP-HPLC. American Journal of PharmTech Research. 2021; 11(3): 36-50.
23. Malviya V, Pande S. A Review of the Most Recent Research on Solid Lipid Nanoparticles, Focusing on Active Compound Encapsulation. Research Journal of Pharmacy and Technology. 2025 Apr 1; 18(4): 1658-62.
24. Mohapatra TK, Subudhi BB. Repurposing of aspirin: Opportunities and challenges. Research Journal of Pharmacy and Technology. 2019; 12(4): 2037-44.
25. Malviya SS, Sarkar BK, Devhare LD, Singh MN. A Textbook of Novel Drug Delivery System. IIP Publication. 2023:1-230.
26. Jarada TN, Rokne JG, Alhajj R. A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. Journal of cheminformatics. 2020 Jul 22; 12(1):46.
27. Malviya V. Design and Characterization of Thermosensitive Mucoadhesive Nasal Gel for Meclizine Hydrochloride: Thermosensitive Nala Gel of Meclizine HCL. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2022 Feb 28;15(1):5782-93.
28. Sadeghi SS, Keyvanpour MR. An analytical review of computational drug repurposing. IEEE/ACM transactions on computational biology and bioinformatics. 2019 Aug 12; 18(2): 472-88.
29. Malviya VR, Pande SD. Road CKN. Preparation ad Evaluation of Zolmitriptan Hydrochloride Lozenge. J Pharma Res. 2019; 8(8): 624-9.
30. Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A. Drug repurposing: progress, challenges and recommendations. Nature reviews Drug discovery. 2019 Jan; 18(1):41-58.
31. Krishnamurthy N, Grimshaw AA, Axson SA, Choe SH, Miller JE. Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC health services research. 2022 Jul 29;22(1):970.
32. Singh TU, Parida S, Lingaraju MC, Kesavan M, Kumar D, Singh RK. Drug repurposing approach to fight COVID-19. Pharmacological reports. 2020 Dec; 72(6):1479-508.
33. Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, Johnston SE, Vrcic A, Wong B, Khan M, Asiedu J. The Drug Repurposing Hub: a next-generation drug library and information resource. Nature medicine. 2017 Apr; 23(4):405-8.
34. Oprea TI, Mestres J. Drug repurposing: far beyond new targets for old drugs. The AAPS journal. 2012 Dec; 14(4):759-63.
35. Malviya V. Preparation and evaluation of emulsomes as a drug delivery system for bifonazole. Indian journal of pharmaceutical education and research. 2021 Jan 1; 55(1):86-94.
36. Yang HT, Ju JH, Wong YT, Shmulevich I, Chiang JH. Literature-based discovery of new candidates for drug repurposing. Briefings in bioinformatics. 2017 May 1; 18(3):488-97.
37. Burange PJ, Tawar MG, Bairagi RA, Malviya VR, Sahu VK, Shewatkar SN, Sawarkar RA, Mamurkar RR. Synthesis of silver nanoparticles by using Aloe vera and Thuja orientalis leaves extract and their biological activity: a comprehensive review. Bulletin of the National Research Centre. 2021 Oct 30;45(1):181.
38. Turabi KS, Deshmukh A, Paul S, Swami D, Siddiqui S, Kumar U, Naikar S, Devarajan S, Basu S, Paul MK, Aich J. Drug repurposing—an emerging strategy in cancer therapeutics. Naunyn-Schmiedeberg's Archives of Pharmacology. 2022 Oct; 395(10): 1139-58.
39. Roy S, Dhaneshwar S, Bhasin B. Drug repurposing: an emerging tool for drug reuse, recycling and discovery. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews. 2021 Jul 1; 13(2): 101-19.
40. Oprea TI, Bauman JE, Bologa CG, Buranda T, Chigaev A, Edwards BS, Jarvik JW, Gresham HD, Haynes MK, Hjelle B, Hromas R. Drug repurposing from an academic perspective. Drug Discovery Today: Therapeutic Strategies. 2011 Dec 1; 8(3-4): 61-9.
41. Fadlalla M, Ahmed M, Ali M, Elshiekh AA, Yousef BA. Molecular docking as a potential approach in repurposing drugs against COVID-19: a systematic review and novel pharmacophore models. Current Pharmacology Reports. 2022 Jun; 8(3): 212-26.
42. Somolinos FJ, León C, Guerrero-Aspizua S. Drug repurposing using biological networks. Processes. 2021 Jun 17; 9(6): 1057.
43. Mohi-Ud-Din R, Chawla A, Sharma P, Mir PA, Potoo FH, Reiner Ž, Reiner I, Ateşşahin DA, Sharifi-Rad J, Mir RH, Calina D. Repurposing approved non-oncology drugs for cancer therapy: A comprehensive review of mechanisms, efficacy, and clinical prospects. European journal of medical research. 2023 Sep 14; 28(1): 345.
44. Yang F, Zhang Q, Ji X, Zhang Y, Li W, Peng S, Xue F. Machine learning applications in drug repurposing. Interdisciplinary Sciences: Computational Life Sciences. 2022 Mar; 14(1): 15-21.
45. Malviya V. Investigation of in-vitro antidiabetic study, antioxidant activity and anthelminthic property of various extracts of bitter cumin seeds: antidiabetic study, antioxidant activity, and anthelminthic property of bitter cumin seeds. International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN). 2023 Jul 31; 16(4): 6855-74.